12.01.2018 • NewsDede WillamsEvonikAcids

Fufeng to Toll Manfacture Evonik’s L-threonine in China

(c) tukkata/Shutterstock
(c) tukkata/Shutterstock

German chemical producer Evonik has signed a toll manufacturing agreement with China’s Fufeng Group that will see Fufeng produce Evonik’s L-threonine amino acid in China, using the German group’s technology.

The Chinese bio-fermentation specialist will use Evonik’s proprietary technology to make the animal nutrition product, which is sold under the ThreAMINO brand name. With the strategic partnership, the German group said it will be able to provide its full portfolio of amino acids to all customers while maintaining a lean asset portfolio.

"Our strategy reflects the recent dynamics of the feed amino acids market and helps Evonik to further optimize its bio amino acid business,” said Emmanuel Auer, head of the Animal Nutrition Business Line. Through the toll-manufacturing deal in China, he said the group is supporting its position in Western and Asian markets. For all customers, supply security, product quality and personal contacts remain the same.

Based in Juna, the Fufeng Group operates several large-scale production facilities in Northern China and counts as the world’s largest producer of starch-based food and feed ingredients, of fermentative feed additives in particular. The collaboration with Evonik will enable the Chinese player to assume an important role as an amino acid supplier.

L-Threonine is an essential amino acid the body cannot produce itself, so that it must be  taken up by the  animal with the feed. An optimal L-threonine level improves feed intake, weight gain and nutritional value of the feed, Evonik said. The Essen-based group has been producing 60 essential amino acids for more than 60 years.

New PMMA compounding line

Separately, Evonik said it plans to start up a new production line for specialty PMMA molding compounds in the first quarter of 2019. It said the unquantified new capacity will nearly double output capability and strengthen its fully integrated methacrylates portfolio.  Construction is due to begin shortly.

The group claims to be the only manufacturer that has fully integrated MMA/PMMA production networks with downstream compounding in the Americas, Europe, and Asia.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
02.07.2025 • News

BASF Completes Acquisition of DOMO Chemicals' Shares in Alsachimie JV

BASF has acquired DOMO Chemicals' 49% stake in the Alsachimie joint venture and is now the sole owner of the production company for essential precursors of polyamide (PA) 6.6, including KA oil, adipic acid and hexamethylenediamine adipate (AH salt) in Chalampé, France. The parties have agreed not to disclose financial details of the transaction.

Photo
02.06.2025 • News

BASF to Acquire Shares in Alsachimie

BASF and DOMO Chemicals have signed an agreement giving BASF the right to acquire DOMO Chemicals' 49% stake in the Alsachimie joint venture, in which BASF currently holds 51%.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.